Zobrazeno 1 - 10
of 414
pro vyhledávání: '"Victoria Carlton"'
Autor:
Carolina Schinke, Antje Hoering, Hongwei Wang, Victoria Carlton, Sharmilan Thanandrarajan, Shayu Deshpande, Purvi Patel, Gabor Molnar, Sandra Susanibar, Meera Mohan, Pankaj Mathur, Muthukumar Radhakrishnan, Shadiqul Hoque, Jorge Jo Kamimoto, Monica Grazziutti, Frits van Rhee, Maurizio Zangari, Giovanni Insuasti-Beltran, Daisy Alapat, Ginell Post, Shmuel Yaccoby, Joshua Epstein, Leo Rasche, Sarah Johnson, Martin Moorhead, Tom Willis, Bart Barlogie, Brian Walker, Niels Weinhold, Faith E Davies, Gareth J. Morgan
Publikováno v:
Haematologica, Vol 102, Iss 8 (2017)
Externí odkaz:
https://doaj.org/article/f623ed3fc1294693a16e2270ad7ee5e1
Autor:
Michael Prados, Michelle Moghadassi, Jennette Sison, Rei Miike, Victoria Carlton, Hywel Jones, Joe Patoka, Karl Kelsey, Joe Wiemels, John Wiencke, Alex McMillan, Margaret Wrensch
Supplementary Data Table 2 from Nonsynonymous Coding Single-Nucleotide Polymorphisms Spanning the Genome in Relation to Glioblastoma Survival and Age at Diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c7d3ca4d2f20593e616f9da35e2ea52
https://doi.org/10.1158/1078-0432.22441716.v1
https://doi.org/10.1158/1078-0432.22441716.v1
Autor:
Michael Prados, Michelle Moghadassi, Jennette Sison, Rei Miike, Victoria Carlton, Hywel Jones, Joe Patoka, Karl Kelsey, Joe Wiemels, John Wiencke, Alex McMillan, Margaret Wrensch
Supplementary Data Table 3 from Nonsynonymous Coding Single-Nucleotide Polymorphisms Spanning the Genome in Relation to Glioblastoma Survival and Age at Diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d8ef74234235980f8688959cfd99a11
https://doi.org/10.1158/1078-0432.22441713.v1
https://doi.org/10.1158/1078-0432.22441713.v1
Autor:
Michael Prados, Michelle Moghadassi, Jennette Sison, Rei Miike, Victoria Carlton, Hywel Jones, Joe Patoka, Karl Kelsey, Joe Wiemels, John Wiencke, Alex McMillan, Margaret Wrensch
Purpose: Our aim was to discover possible inherited factors associated with glioblastoma age at diagnosis and survival. Although new genotyping technologies allow greatly expanded exploration of such factors, they pose many challenges.Experimental De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49a225d46a99de55adc477b7622a772c
https://doi.org/10.1158/1078-0432.c.6518670.v1
https://doi.org/10.1158/1078-0432.c.6518670.v1
Autor:
Laure Fresard, Keith Nykamp, Nick Kamp-Hughes, John Vincent, Sarah Albritton, Victoria Carlton, Hio Chung Kang, Kate Krempely, Carolina Pardo
Publikováno v:
Cancer Genetics. :5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dea19c720a136d6d10fa7ea28a0f9a8
https://doi.org/10.1016/j.cancergen.2022.10.017
https://doi.org/10.1016/j.cancergen.2022.10.017
Autor:
Keith Nykamp, Nick Kamps-Hughes, John Vincent, Sarah Albritton, Laure Fresard, Victoria Carlton, Hio Chung Kang, Kate Krempely, Carolina Pardo
Publikováno v:
Genetics in Medicine. 24:S240-S241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56d9c0ec8dc256d0258ae1e27d531217
https://doi.org/10.1016/j.gim.2022.01.417
https://doi.org/10.1016/j.gim.2022.01.417
Autor:
Elizabeth R. Starks, Victoria Carlton, Veena Rajaraman, Katya Kosheleva, Tamsen Dunn, Nick Kamps-Hughes, Laurie Gay, Meaghan Russell, Sarah Albritton, John J. Vincent, Nhu Ngo
Publikováno v:
Cancer Research. 82:1230-1230
Introduction: NGS-based tests that include biomarkers such as microsatellite instability (MSI) and tumor mutational burden (TMB) increase patient access to immune checkpoint inhibitors and improve the personalization of cancer care. Tumor-only NGS te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9611052022ea76b4e3394682253e8a41
https://doi.org/10.1158/1538-7445.am2022-1230
https://doi.org/10.1158/1538-7445.am2022-1230
Autor:
Philippe Moreau, Laurent Garderet, Bertrand Arnulf, Sabrina Maheo, Lotfi Benboubker, Mamoun Dib, Sabine Brechignac, Nelly Robillard, Mohamad Mohty, Margaret Macro, Brigitte Pegourie, Thierry Facon, Brigitte Kolb, Karim Belhadj, Nikhil C. Munshi, Bruno Royer, Olivier Decaux, Arnaud Jaccard, Valérie Lauwers-Cances, Marie-Lorraine Chretien, Anne-Marie Stoppa, Hervé Avet-Loiseau, Xavier Leleu, Kenneth C. Anderson, Jean-Richard Eveillard, Martin Moorhead, Chantal Doyen, Cecile Fohrer, Lionel Karlin, Jill Corre, Victoria Carlton, Paul G. Richardson, Malek Faham, Jean-Luc Harousseau, Michel Attal, Nathalie Meuleman, Thomas D. Willis, Aurore Perrot, Cyrille Hulin, Thomas Dejoie
Publikováno v:
Blood
Blood, American Society of Hematology, 2018, 132 (23), pp.2456-2464. ⟨10.1182/blood-2018-06-858613⟩
Blood, Vol. 132, no. 23, p. 2456-2464 (2018)
Blood, American Society of Hematology, 2018, 132 (23), pp.2456-2464. ⟨10.1182/blood-2018-06-858613⟩
Blood, Vol. 132, no. 23, p. 2456-2464 (2018)
IF 15.132 (2017); International audience; The introduction of novel agents has led to major improvements in clinical outcomes for patients with multiple myeloma. To shorten evaluation times for new treatments, health agencies are currently examining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500fa1b818ac6de4e41772025c8d41b8
https://doi.org/10.1182/blood-2018-06-858613
https://doi.org/10.1182/blood-2018-06-858613
Autor:
Yoshitaka Zaimoku, Yasushi Terasaki, Tsutomu Sato, Martin Moorhead, Shinji Nakao, Katherine A. Kong, Naoki Takezako, Kenji Yokoyama, Hiroyuki Takamatsu, Hideo Yagi, Ryoichi Murata, Malek Faham, Morio Matsumoto, Rachel K Wee, Shigeki Ito, Victoria Carlton, Kinya Ohata, Toshiro Kurokawa, Takashi Yoshida, Toshihiro Miyamoto, Kosei Matsue, Jianbiao Zheng
Publikováno v:
British Journal of Haematology. 183:664-668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84dd63a8387cdf35282c76d82a08f300
https://doi.org/10.1111/bjh.15002
https://doi.org/10.1111/bjh.15002
Autor:
Kosei Matsue, Tomotaka Yoshida, Malek Faham, Tsutomu Sato, Martin Moorhead, Shigeki Ito, Victoria Carlton, Hiroyuki Takamatsu, Jianbiao Zheng, Toshiro Kurokawa, Shinji Nakao, Ryoichi Murata, Kinya Ohata, Naoki Takezako, Morio Matsumoto, Hideo Yagi, Katherine A. Kong, Kozue Yokoyama, Yasushi Terasaki, Toshihiro Miyamoto
Publikováno v:
Annals of Oncology
Background Most patients with multiple myeloma (MM) are considered to be incurable, and relapse owing to minimal residual disease (MRD) is the main cause of death among these patients. Therefore, new technologies to assess deeper response are require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705b370a018a34ac2cb1cb736fe2f905
http://europepmc.org/articles/PMC5834061
http://europepmc.org/articles/PMC5834061